国际脑血管病杂志
國際腦血管病雜誌
국제뇌혈관병잡지
INTERNATIONAL JOURNAL OF CEREBROVASCULAR DISEASES
2010年
5期
347-351
,共5页
颅内动脉疾病%颅内动脉粥样硬化%卒中%脑缺血发作,短暂性%血小板聚集抑制剂%羟基甲基戊二酰基-CoA还原酶抑制剂%抗凝药%支架
顱內動脈疾病%顱內動脈粥樣硬化%卒中%腦缺血髮作,短暫性%血小闆聚集抑製劑%羥基甲基戊二酰基-CoA還原酶抑製劑%抗凝藥%支架
로내동맥질병%로내동맥죽양경화%졸중%뇌결혈발작,단잠성%혈소판취집억제제%간기갑기무이선기-CoA환원매억제제%항응약%지가
Intracranial arterial diseases%Intracranial arteriosclerosis%Stroke%Ischemic attack,transient%Risk factors%Platelet aggregation nhibitors%Anticoagulants%Hydroxymethylglutaryl-CoA reductase inhibitors%Stents
我国每年新发卒中200多万例,其中绝大部分由脑血管狭窄引起.动脉粥样硬化是脑血管狭窄的主要原因,有效治疗颅内动脉粥样硬化能明显降低卒中的发病率.然而,目前有关颅内动脉粥样硬化性狭窄的治疗并不规范,文章就近年来有关颅内动脉粥样硬化性狭窄的治疗方法做一综述,为颅内动脉粥样硬化性狭窄治疗规范的制定提供依据.
我國每年新髮卒中200多萬例,其中絕大部分由腦血管狹窄引起.動脈粥樣硬化是腦血管狹窄的主要原因,有效治療顱內動脈粥樣硬化能明顯降低卒中的髮病率.然而,目前有關顱內動脈粥樣硬化性狹窄的治療併不規範,文章就近年來有關顱內動脈粥樣硬化性狹窄的治療方法做一綜述,為顱內動脈粥樣硬化性狹窄治療規範的製定提供依據.
아국매년신발졸중200다만례,기중절대부분유뇌혈관협착인기.동맥죽양경화시뇌혈관협착적주요원인,유효치료로내동맥죽양경화능명현강저졸중적발병솔.연이,목전유관로내동맥죽양경화성협착적치료병불규범,문장취근년래유관로내동맥죽양경화성협착적치료방법주일종술,위로내동맥죽양경화성협착치료규범적제정제공의거.
More than 2 million strokes occur in china each year,most of which are caused by cerebrovascular stenosis. Atherosclerosis is the main reason for cerebrovascular stenosis. The effective treatment of intracranial atherosclerosis can significantly decrease the incidence of stroke. However,at present,about the treatment of intracranial atherosclerotic stenosis has not been standardized. This article reviews about the treatment methods for intracranial atherosclerotic stenosis in recent years and provides the basis for the development of standardized
treatment of intracranial atherosclerotic stenosis.
